Cambridge Launches Multidisciplinary Synthetic Bio, Big Data Initiatives | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Cambridge said today it has launched new multidisciplinary, collaborative research programs focused on synthetic biology and big data, as well as cardiovascular disease and public policy.

The university has added the four new subject areas into its Strategic Research Initiative program, which brings together academics from different disciplines to harness their expertise and make a “real-world impact,” Cambridge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.